An Individualized Approach to Psoriasis: Integrating the Use of Biologics in the Long-term Management of the Disease and Associated Comorbidities

Target Audience:

This activity is intended for medical dermatologists and other healthcare professionals involved in the management of patients with psoriasis.

Program Overview:

This enduring activity, Maui Derm & AAD Roving Reporter, discusses the management of patients with psoriasis with updates since the Maui Derm and American Academy of Dermatology meetings in relation to the management of patients with psoriasis. Maui Derm was held January 26 – 30 in Maui, Hawaii and AAD was held March 21 - 25, 2014 in Denver, Colorado.

Disclosure Of Unlabeled Use:

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During the course of this lecture, Dr. Gelfand may mention the use of medications for both FDA-approved and non-approved indications.

Disclaimer:

Med Learning Group makes every effort to develop CME activities that are scientifically based.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Method Of Participation:

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CE credit participants must:

  • Read the learning objectives and faculty disclosures.
  • Complete the pre-test.
  • Participate in the activity.
  • Complete the post-test and activity evaluation
  • Physicians who successfully complete the post-test and evaluation will receive CME credit.
  • All non-physician participants who successfully complete the post-test and evaluation will receive a certificate of participation.
  • All certificates will be emailed within 30 days.

For CME questions, please contact: Med Learning Group at info@medlearninggroup.com

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://www.medlearninggroup.com/privacy-policy/

Course Viewing Requirements:

PC
Internet Explorer (v6 or greater), or Firefox

MAC
Safari

RELEASE DATE: April 25, 2014
EXPIRATION DATE: April 24, 2015

MEDIUM: Internet

Estimated Time to Complete This Educational Activity: 60 minutes  

Participation Statement:

This educational activity provides training necessary for licensed attendees to maintain state licensing requirements. The tuition for this educational activity is subsidized in part by unrestricted educational grants, including for those attendees who have successfully completed the state licensing requirements for their respective fields. This subsidy is reflected in the registration fees for this activity.

Accreditation:

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This CME activity was planned and produced in accordance with the ACCME Essentials.

AAD Credit Designation:

The Med Learning Group's An Individualized Approach to Psoriasis: Integrating the Use of Biologics in the Long-term Management of the Disease and Associated Comorbidities (Program #65104) is recognized by the American Academy of Dermatology for 1 AAD Recognized Credit(s) and may be used toward the American Academy of Dermatology’s Continuing Medical Education Award.

Credit Designation:

Med Learning Group designates this enduring web activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Listing:

Joel M. Gelfand, MD, MSCE
Associate Professor of Dermatology
Associate Professor of Epidemiology
University of Pennsylvania
Philadelphia, Pennsylvania

Course Reviewer:

Katherine Galluzzi, DO, CMD, FACOFP dist.
Professor and Chairperson, Department of Geriatrics
Philadelphia College of Osteopathic Medicine
Attending Physician, Family Medicine
Tenet Roxborough Memorial Hospital
Philadelphia, Pennsylvania

Objectives:

  • Evaluate the clinical data regarding the use of biologics in the treatment of psoriasis and discuss treatment decision-making process
  • Critically review the evidence regarding choice of appropriate endpoints for the management of psoriasis
  • Understand psoriasis patients

Financial Disclosure:

Dr. Gelfand is an investigator and/or consultant for Amgen, Abbvie, Jansen, Merck, Pfizer, Lilly Celgene, Novartis, and Genentech.

Course Reviewer
Katherine Galluzzi, DO, CMD, FACOFP dist.
Professor and Chairperson, Department of Geriatrics
Philadelphia College of Osteopathic Medicine
Attending Physician, Family Medicine
Tenet Roxborough Memorial Hospital
Philadelphia, Pennsylvania

MLG Course Reviewer - - Dr. Katherine Galluzzi has no relevant financial relationships to disclose.

The staff, planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group has nothing to disclose.
Lauren Welch, VP for Outcomes and Accreditation for Med Learning Group has nothing to disclose.
Chris Drury, Medical and Scientific Services for Med Learning Group has nothing to disclose.